The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.514
Bid: 1.518
Ask: 1.528
Change: 0.002 (0.13%)
Spread: 0.01 (0.659%)
Open: 1.52
High: 1.53
Low: 1.51
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB's FY22 IFRS 9 Financial Statements

20 Mar 2023 18:26

RNS Number : 5862T
Commercial Intnl Bank (Egypt) SAE
20 March 2023
 

http://www.rns-pdf.londonstockexchange.com/rns/5862T_1-2023-3-20.pdf

 

Consolidated Income Statement for the Year Ended December 31, 2022

 

 

Notes

Dec. 31, 2022

Dec. 31, 2021

EGP Thousands

EGP Thousands

 

Interest and similar income

 

55,723,701

 

45,078,169

Interest and similar expense

  (24,828,731)

  (20,204,272)

Net interest income 3

  30,894,970

24,873,897

 

Fee and commission income

 

5,555,082

 

4,045,573

Fee and commission expense

  (2,476,945)

  (1,655,096)

Net fee and commission income 4

  3,078,137

2,390,477

Dividend income 5

 

52,411

 

59,725

Net trading income 6

2,827,922

774,992

Profits on financial investments 20

1,162,195

594,863

Administrative expenses 7

(9,460,461)

(7,787,584)

Other operating expenses 8

(4,562,700)

(1,673,546)

Impairment charges for credit losses 9

(1,584,942)

(1,679,747)

Bank's share in the (loss)/profit of associates 12

  (19,253)

  14,996

Profit before income tax from continuing operations

  22,388,279

17,568,073

Income taxes 10

 

  (7,769,136)

 

(5,565,599)

 

Net profit for the year

 

  14,619,143

 

12,002,474

 

 

Attributable to:

Equity holders of the parent

14,561,381

12,006,925

Non-controlling interest

57,762

(4,451)

Net Profit for the year

  14,619,143

12,002,474

Earning per share 11

Basic attributable to equity holders of the parent

4.88

4.03

Diluted attributable to equity holders of the parent

4.84

3.99

 

 

The accompying notes from 1 to 42 form an integral part of these consolidated financial statements.

 

 

 

Hussein Abaza

Sherif Samy

CEO & Managing director Chairman

20- March -2023 20- March -2023

 

 

 

 

Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2022

Dec. 31, 2022

Dec. 31, 2021

EGP Thousands

EGP Thousands

Profit for the year

14,619,143

12,002,474

Comprehensive income items that will not be reclassified to the Profit or Loss:

Change in fair value of equity instruments measured at fair value through comprehensive income

233,046

(149,323)

Tax impact for investments that will not be reclassified to Income

Statement

(61,753)

13,489

Transferred to RE from financial assets at fair value through

comprehensive income

(3,436)

(177,488)

Comprehensive income items that is or may be reclassified to the

profit or loss:

Change in fair value of debt instruments measured at fair value

through comprehensive income

(14,691,866)

(2,181,779)

Change in fair value from selling FVOCI financial instruments

(1,116,776)

(702,776)

Cumulative foreign currencies translation differences

181,324

(4,218)

Tax impact for OCI investment that will be reclassified to Income

Statement

1,215,530

(109,394)

Effect of ECL in fair value of debt instruments measured at fair value through OCI

  455,047

  (93,566)

Total comprehensive income for the year

  830,259

  8,597,419

As follows:

Bank's shareholders

772,497

8,601,870

Non-controlling interest

  57,762

  (4,451)

Total comprehensive income for the year

  830,259

  8,597,419

 

 

Consolidated Statement of Financial Position as at December 31, 2022

 

 

Notes

Dec. 31, 2021

EGP Thousands

 

Assets

Cash and balances at the central bank

13

47,492,549

43,492,248

Due from banks

14

133,856,720

80,141,769

Loans and advances to banks, net

15

2,978,197

312,216

Loans and advances to customers, net

16

193,599,872

145,575,243

Financial Assets at fair value through profit or loss

19

247,324

443,859

Derivative financial instruments

17

1,939,961

225,376

Financial Assets at fair value through OCI

19

208,144,247

197,238,721

Financial Assets at amortized cost

19

34,524,760

20,547,465

Right of use assets

23

1,726,082

1,084,585

Investments in associates

21

186,062

205,315

Other assets

22

14,521,427

11,207,128

Intangible assets

38

51,831

51,831

Goodwill

38

206,287

206,287

Deferred tax assets

10.2

185,745

456,002

Property and equipment

23

  2,405,434

  2,461,116

Total assets

  642,066,498

503,649,161

Liabilities and equity

Liabilities

Due to banks

24

3,496,698

866,056

Due to customers

25

531,616,550

407,241,538

Lease liabilities

23

1,690,099

1,087,820

Derivative financial instruments

17

219,752

265,470

Issued debt instruments

18

2,456,607

1,557,263

Other liabilities

27

17,700,479

13,710,791

Current Tax liability

3,051,583

2,234,985

Other loans

26

7,978,975

5,140,782

Provisions

28

  7,067,599

  3,541,462

Total liabilities

  575,278,342

  435,646,167

Equity

Issued and paid in capital

29

29,825,134

19,702,418

Reserves

30

19,342,866

33,552,794

Reserve for employee stock ownership plan (ESOP)

30

1,895,435

1,674,392

Retained earnings

30

  15,144,290

  12,618,855

Total equity attributable to equity holders of the parent

66,207,725

67,548,459

Non-controlling interest

39

580,431

454,535

Total equity

  66,788,156

  68,002,994

Total liabilities and equity

  642,066,498

503,649,161

 

The accompying notes from 1 to 42 form an integral part of these consolidated financial statements.

 

 

Hussein Abaza

CEO & Managing director

20- March -2023

 

Sherif SamyChairman

20- March -2023

 

Consolidated Statement of Changes in Shareholders' Equity

 

 

 

Dec. 31, 2021 Issued and paid in capital

 

Reserve for employee stock ownership plan (ESOP)

 

Retained earnings Reserves Total Non-controlling

interest

 

 

Total equity

19,702,418

1,674,392

12,618,855

33,552,794

67,548,459

454,535

68,002,994

-

-

14,561,381

-

14,561,381

57,762

14,619,143

10,122,716

-

-

(10,000,000)

122,716

-

122,716

 

-

 

723,965

 

-

 

-

 

723,965

 

-

 

723,965

-

-

(3,019,442)

-

(3,019,442)

(10,247)

(3,029,689)

-

(502,922)

(9,016,504)

(4,209,928)

(13,729,354)

78,381

(13,650,973)

 

29,825,134

 

1,895,435

 

15,144,290

 

19,342,866

 

66,207,725

 

580,431

 

66,788,156

 

 

 

Beginning balance at 1st of Jan 2021 14,776,813 1,064,648 9,534,429 32,939,079 58,314,969 483,055 58,798,024

 

Total comprehensive income - - 12,006,925 - 12,006,925 (4,451) 12,002,474

 

Capital increase

4,925,605

-

-

(4,925,605)

-

-

-

Reserve for employee stock ownership plan (ESOP)

 

-

 

609,744

 

-

 

-

 

609,744

 

-

 

609,744

Dividend

-

-

(156,389)

-

(156,389)

(24,069)

(180,458)

Transferred to reserves

-

-

(8,766,110)

5,539,320

(3,226,790)

-

(3,226,790)

Balance at 31 December 2021

19,702,418

1,674,392

12,618,855

33,552,794

67,548,459

454,535

68,002,994

Beginning balance at 1st of Jan 2022

Total comprehensive income

Capital increase

Reserve for employee stock ownership plan (ESOP)

Dividend

Transferred to reserves

 

Balance at 31 December 2022

 

 

 

 

Notes

 

 

Cash flow from operating activities

Dec. 31, 2022

EGP Thousands

Dec. 31, 2021

EGP Thousands

Profit before income tax from continued operations

22,388,279

17,568,073

Adjustments to reconcile profits to net cash provided by operating activities

Fixed assets depreciation

885,801

885,060

Impairment charge for credit losses (Loans and advances to customers)

1,043,776

1,756,505

Other provisions charges

2,134,462

380,459

Impairment charge for other assets

(277,766)

31,975

Impairment charge for credit losses (due from banks)

8,395

16,808

Exchange revaluation differences for financial assets at fair value through OCI and AC

(7,477,865)

17,261

Impairment (Reversal of impairment) charge for credit losses (financial investments)

524,838

(93,566)

Utilization of other provisions

(3,126)

(45,483)

Other provisions no longer used

(172)

(2,451)

Impairment of intangible assets

206,287

206,287

Exchange differences of other provisions

1,394,973

(15,243)

Impairment (Reversal of impairment) charges of investments in associates

-

107,913

Profits from selling property, plant and equipment

(2,208)

(2,947)

Losses from selling financial investments

(1,162,195)

(702,776)

Shares based payments

723,965

609,744

Bank's share in the profits / losses of associates

  17,680

  (14,996

Operating profits before changes in working capital

20,405,124

20,702,623

Net decrease (increase) in working capital

Due from banks

(25,811,654)

(17,183,300)

Financial assets at fair value through profit or loss

240,987

118,972

Derivative financial instruments

(1,760,303)

(42,220)

Loans and advances to banks and customers

(51,705,061)

(27,280,547)

Other assets

(2,862,478)

(2,135,921)

Due to banks

2,630,642

(7,951,479)

Due to customers

124,375,012

66,072,088

Current income tax obligations paid

(3,293,520)

(3,444,749)

Other liabilities

  3,989,688

  (1,359,238

Net cash generated from operating activities

  66,208,437

27,496,229

 

Cash flow from investing activities

Payment for purchases of associates

 

-

 

(158,360)

Payment for purchases of property, equipment and branches constructions

(1,033,499)

(981,186)

Proceeds from selling property and equipment

2,208

2,947

Proceeds from redemption of financial assets at amortized cost

6,738,937

4,741,459

Payment for purchases of financial assets at amortized cost

(19,908,223)

(3,844)

Payment for purchases of financial assets at fair value through OCI

(45,665,232)

(250,679,698)

Proceeds from selling financial assets at fair value through OCI

  26,046,482

  206,611,955

Net cash generated from (used in) investing activities

  (33,819,327)

(40,466,727)

 

 
Consolidated Statement of Cash Flow for the Year Ended December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Dec. 31, 2022

Dec. 31, 2021

EGP Thousands

EGP Thousands

Cash flow from financing activities

Other loans

2,838,193

(2,606,164)

Other loans - new loans obtained in the year

102,613

24,334

Other loans - loans repaid in the year

(554,539)

(2,625,878)

Other loans - movement in foreign exchange rate

3,290,119

(4,620)

Dividends paid

(3,019,442)

(156,389)

Issued debt instruments ( the effect of changes in foregin exchange rate )

899,344

-

Cash payments for lease (principle and interest)

(498,794)

(242,292)

Capital increase

  122,716

  -

Net cash generated from (used in) financing activities

  342,017

(3,004,845)

 

 

Net (decrease) increase in cash and cash equivalent during the year

 

 

32,731,127

 

 

(15,975,343)

Beginning balance of cash and cash equivalent

  50,374,942

  66,350,285

Cash and cash equivalent at the end of the year

  83,106,069

50,374,942

 

Cash and cash equivalent comprise:

Cash and balances at the central bank

13

47,492,549

43,492,248

Due from banks with maturities of 3 months or less

14

76,096,552

44,983,081

Treasury bills with maturities of three months or less

19

10,575

549

Obligatory reserve balance with CBE

13

  (40,493,607)

  (38,100,936

Total cash and cash equivalent

31

  83,106,069

50,374,942

 

Interest received in cash

Dec.31, 2022

Dec.31, 2021

EGP Thousands

EGP Thousands

From operating activities:

Loans and advances

24,170,943

18,206,717

Due to customers

23,237,484

18,950,534

 

Dec.31, 2022

 

Dec.31, 2021

EGP Thousands

EGP Thousands

From investing activities:

Financial assets at FVOCI

26,107,850

20,516,144

Financial assets at AC

3,136,458

3,653,803

 

Dec.31, 2022

 

Dec.31, 2021

EGP Thousands

EGP Thousands

From Financing activities:

Other loans

  455,183

322,522

 

 
Consolidated Statement of Cash Flow for the Year Ended December 31, 2022 (Cont.)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR PPUPGWUPWGRU
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.